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 2 
Abstract  28 
One of the key advantages of assessing the hepatotoxic potential of xenobiotics in spheroids 29 
rather than monolayer cell culture is the existence of a more physiologically relevant testing 30 
environment. Three-dimensional cultures support spatial gradients in nutrients such as oxygen 31 
that can be exploited to better represent in vivo gradients that exist along a fundamental sub-32 
unit of liver microarchitecture, the liver sinusoid. The physical and physiological processes that 33 
result in the establishment of such gradients can be described mathematically. Quantification 34 
of the rates governing these processes and optimisation of cell culture conditions can be 35 
performed in silico to better inform experimental design. In this study, we take into account 36 
cell line-specific physiological properties, spheroid size and the impact of experimental 37 
equipment geometries in order to demonstrate how mathematical models can be optimised to 38 
achieve specific in vivo-like features in different scenarios. Furthermore, the sensitivity of such 39 
optimised gradients is analysed with respect to culture conditions and considerations are given 40 
to prevent the emergence of hypoxic regions in the spheroid. The methodology presented 41 
provides an enhanced understanding of the mechanisms of the system within this simulated in 42 
vitro framework such that experimental design can be more carefully calibrated when 43 
conducting experiments using hepatic spheroids. 44 
Keywords: Liver spheroids; HepG2; HepaRG; Hypoxia; Oxygen gradient; In silico modelling.  45 
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1 Introduction 46 
Two-dimensional (2D) cell culture systems have been extensively used to enhance our 47 
understanding of human biology with applications ranging from the study of pathophysiology 48 
at the cellular level to the pharmacology and toxicology of novel drugs. However, there remains 49 
a considerable disparity between in vitro experimental findings and in vivo relevance, 50 
motivating the need for improved in vitro methods. The enhanced physiological relevance of 51 
three-dimensional (3D) in vitro models provides an important link between 2D in vitro models 52 
and in vivo whole-body biology (Yamada & Cukierman, 2007). While many 3D model 53 
systems, from scaffold-based models to microfluidic bioreactors, are now being employed to 54 
increase translational applicability, the use of spheroid models in particular has become 55 
progressively important to fundamental medical research and safety assessment (Kyffin et al., 56 
2018). 3D spheroids represent a convenient and versatile in vitro model that improves 57 
physiological relevance, cell morphology and functionality (compared to 2D systems), yet are 58 
simple to deploy, cost-effective and amenable to higher throughput techniques. Although these 59 
systems inevitably lack certain physiological complexities (e.g. vasculature) as a consequence 60 
of their relative simplicity, other features such as in vivo-like gradients can be established with 61 
the move to three dimensions. Of paramount importance in these physiological gradients is 62 
oxygen. 63 
Physiological oxygen gradients are a prime example of homeostasis within healthy cells and 64 
tissues and significant disruption to oxygen availability can lead to apoptosis and necrosis. 65 
Hypoxia is a prevalent feature in the growth stages of solid tumours due to the rapid growth 66 
characteristic of mutated cancer cells causing an abnormal distribution of cells and nutrient-67 
supplying blood vessels (Vaupel et al., 1989, Muz et al., 2015). As cancer cells typically 68 
proliferate more rapidly than normal cells, a tumour mass is soon formed that is unable to be 69 
adequately supplied by the surrounding vasculature, that also tends to be immature and poorly 70 
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formed. A hypoxic region is formed in the centre of the tumour due to the distance between the 71 
oxygen supply and this core of cells. This process is symptomatic of an early-stage tumour, 72 
otherwise known as an avascular tumour, as the tumour has not yet induced the production of 73 
its own blood vessel network (Brown & Giaccia, 1998, Riffle & Hegde, 2017). Similarly, 74 
hyperoxic conditions can lead to the generation of reactive oxygen species and oxidative stress, 75 
and thus there exists a bounded range of oxygen tensions that is functionally optimal for each 76 
tissue (Carreau et al., 2011, Lee et al., 2014). Avascular tumours are studied experimentally by 77 
culturing cancer cells as spheroids as they share similar growth kinetics (Freyer, 1988, Grimes 78 
et al., 2016). The avascular phase of the life cycle of a tumour covers the initial mutations of 79 
normal cells through to a diffusion-limited steady state where the tumour’s growth is limited 80 
by a balance between nutrient consumption and nutrient supply via diffusion. Mathematical 81 
modelling can facilitate the refinement and optimisation of in vitro studies to more accurately 82 
translate these results to a more physiologically realistic in vivo scenario (Williams et al., 2013). 83 
The importance of understanding the local environment and mechanisms within tumour 84 
spheroids to develop medical applications has led to considerable mathematical modelling 85 
efforts in this area. Some work has focused on reproducing growth and development processes 86 
(Chaplain, 1996, Grimes et al., 2016), while others investigate the effects of various oxygen 87 
consumption kinetics in different geometries and hypoxic environments (Grimes et al., 2014b, 88 
Grimes et al., 2014a, Leedale et al., 2014). Acknowledgement of the importance of spatial 89 
dynamics in spheroids has also led to mathematical models that simulate 3D pharmacological 90 
processes such as drug delivery and metabolism (Ward & King, 2003, Mehta et al., 2012).  91 
The spatial heterogeneity, or zonation, observed in tumours is a key characteristic that must be 92 
addressed when modelling these systems. These spatial features are also an essential 93 
characteristic of other physiological environments such as the primary detoxification system 94 
of the body, the liver, and in particular the hepatic lobule and liver sinusoid (Jungermann & 95 
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Kietzmann, 2000). The spatial gradients that exist within the sinusoid microenvironment 96 
impact upon overall hepatocyte function, metabolic capabilities and susceptibility to toxins 97 
with respect to location (Lee-Montiel et al., 2017). Therefore, cellular spheroids provide 98 
effective in vitro tools to study the pharmacological and toxicological effects of drugs in the 99 
liver throughout the local microenvironment by replicating physiologically relevant features 100 
within these 3D structures.  101 
The oxygen gradient is a key characteristic of the liver sinusoid that must be maintained in 102 
spheroids in order to preserve this in vivo-like zonation (Figure 1), which ranges from 65 103 
mmHg in the periportal region of the sinusoid to 35 mmHg at the central vein (Jungermann & 104 
Keitzmann, 1996, Jungermann & Kietzmann, 2000). The oxygen gradient is primarily 105 
dependent on the supply of oxygen, flow rate, length of sinusoid and cellular uptake. For in 106 
vitro spheroid models that do not include flow, their size can theoretically be optimised in order 107 
to recapitulate the same range of oxygen concentrations from boundary to core. This range 108 
would then provide the appropriate environment to make the test system more comparable 109 
when studying effects of cell function and spatial variation in metabolism between periportal 110 
and perivenous (centrilobular) regions. Indeed, the role of the oxygen gradient in regulating 111 
metabolic zonation is critically important for pharmacological studies, whether or not this 112 
regulation is direct or via downstream signalling (Kietzmann, 2017). The supply of oxygen in 113 
vitro is dependent on the externally controlled atmosphere, type and volume of culture media 114 
(which can be controlled in vitro), and diffusion of oxygen through the media and spheroid. 115 
The length of sinusoid, which is assumed to be constant and regular in vivo, is effectively 116 
represented by the radius of the in vitro spheroid. All of these parameters that determine the 117 
hepatic oxygen gradient in vitro can be optimised using a suitable mathematical model.  118 
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 119 
Figure 1: A schematic representation of the liver sinusoid. Mixed blood from the portal vein 120 
and the oxygen-carrying hepatic arteriole flows towards the central vein where it is drained 121 
from the liver lobule. As blood flows from the periportal region to the perivenous 122 
(centrilobular) region, oxygen is removed from the blood by hepatocytes establishing an 123 
oxygen gradient ranging from 65 mmHg (periportal) to 35 mmHg (perivenous). 124 
 125 
2 Materials and methods 126 
2.1 Model derivation 127 
2.1.1 Model I: Spheroid only 128 
The mathematical model of spatiotemporal oxygen dynamics throughout the spheroid includes 129 
diffusion and oxygen uptake terms in a continuum approach. We assume that oxygen 130 
consumption is dependent on the local oxygen concentration in a non-linear manner such that 131 
the consumption rate saturates for higher oxygen levels. Therefore, we describe the oxygen 132 
dynamics within the spheroid using the following partial differential equation (PDE):  133 
𝜕𝐶
𝜕𝑡
= 𝐷1∇
2𝐶 −
𝑉𝑚𝑎𝑥𝐶
𝐶 + 𝐾𝑚
, 
 
𝒙 ∈ Ω. (1) 
Oxygen concentration (mol/m3) is represented by 𝐶, 𝐷1 is the diffusion rate constant in m
2/s 134 
(assumed to be independent of radial position), 𝑉𝑚𝑎𝑥 is the maximum consumption rate in 135 
65 mmHg 
35 mmHg 
Portal vein 
Hepatic arteriole 
Central Vein 
Hepatocytes 
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mol/m3/s and 𝐾𝑚 represents the oxygen concentration at which consumption is half maximal 136 
(mol/m3). Time is given by 𝑡 while 𝒙 represents the spatial vector with the equation being 137 
considered within domain Ω (the spheroid). Since we will be looking at oxygen dynamics that 138 
occur on a much faster timescale than cell cycle dynamics (growth and division) we assume 139 
the radius of the spheroid to be constant, 𝑅. The system is assumed to be at steady state in a 140 
radially symmetric sphere (see Figure 2A) and is presented in spherical coordinates in equation 141 
(2) so that the problem is reduced to a 1-dimensional equation in variable 𝑟, the radial 142 
coordinate. The following system (writing the Laplacian operator with respect to the radial 143 
coordinate) is used to describe steady state spatial oxygen dynamics in a radially-symmetric 144 
sphere: 145 
𝐷1 
𝑟2
𝜕
𝜕𝑟
(𝑟2
𝜕𝐶
𝜕𝑟
) −
𝑉𝑚𝑎𝑥𝐶
𝐶 + 𝐾𝑚
= 0, 
 
𝑟 ≤ 𝑅, (2) 
𝜕𝐶
𝜕𝑟
= 0, 
 
𝑟 = 0.     (3) 
The concentration of oxygen at the boundary of the sphere is fixed such that 146 
𝐶 = 𝐶𝑅 ,  𝑟 = 𝑅. (4) 
Initially the oxygen concentration is given by 𝐶(𝑟, 0) = 𝐶𝑅 ∀ 𝑟 ∈ 𝛺. 147 
2.1.2 Model II: Spheroid in well 148 
Model I requires the oxygen concentration at the spheroid boundary to be fixed at a 149 
physiologically relevant value (periportal blood/65 mmHg). However, this is difficult to 150 
calibrate in vitro since oxygen is not directly controlled at this region. The oxygen 151 
concentration at the boundary of a spheroid cultured in vitro is dependent on multiple local 152 
environmental factors such as external oxygen concentration at the air/media interface, 153 
diffusion rate of oxygen within the media, and the volume of media used. Furthermore, the 154 
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mathematical problem is not simply radially symmetric in 3D spherical coordinates due to the 155 
geometry of the equipment used for cell culture, i.e. the physical structure of the well, and the 156 
position of the spheroid. To represent these features, we have developed Model II based on the 157 
in vitro geometry of Ultra-Low Attachment (ULA) plate wells with media (see Figure 2B). 158 
Similar geometrical features are also relevant for other standard culture systems such as 159 
agarose-coated 96 well plates, although these may exhibit more variation due to the formation 160 
of the agarose layer. Therefore, we impose ULA plate geometry for more consistency within 161 
the mathematical model simulations. Understanding the impact of culture conditions and 162 
geometry on oxygen dynamics is known to be critical in order to maintain hepatocyte viability 163 
and functionality in vitro and has previously been modelled for 2D monolayers (Yarmush et 164 
al., 1992). Model II is therefore an extension of Model I used to take into account a 165 
representative 3D in vitro environment and associated geometries.  166 
Model II incorporates a realistic in vitro environment within the model geometry such that 167 
oxygen dynamics are modelled in cylindrical coordinates with radial symmetry about the axis 168 
through the centre of the well. Therefore, the steady state spatial oxygen dynamics within the 169 
hepatic spheroid are governed by the following PDE: 170 
𝐷1
𝑟
𝜕
𝜕𝑟
(𝑟
𝜕𝐶
𝜕𝑟
) + 𝐷1
𝜕2𝐶
𝜕𝑧2
−
𝑉𝑚𝑎𝑥𝐶
𝐶 + 𝐾𝑚
= 0. (5) 
Note that this mathematical representation could be more broadly applied to oxygen dynamics 171 
in other cell-based spheroids with appropriate changes in model parameterisation. In Model II, 172 
oxygen concentration in the media outside the spheroid is also considered, where there is no 173 
consumption and simple diffusion governs the spatial dynamics. Oxygen diffuses at a rate, 𝐷2, 174 
in the outer medium and thus we have the following equation to represent oxygen dynamics 175 
outside the sphere: 176 
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𝐷2
𝑟
𝜕
𝜕𝑟
(𝑟
𝜕𝐶
𝜕𝑟
) + 𝐷2
𝜕2𝐶
𝜕𝑧2
= 0, (6) 
Oxygen concentration is fixed at the air/media interface boundary condition, 𝐶 = 𝐶𝐴, while 177 
zero-flux boundary conditions are imposed at all other boundaries of the geometry (walls of 178 
the well), i.e., ∇𝐶 ⋅ 𝐧 = 0, where 𝐧 is the outward-pointing unit normal vector. Initial 179 
conditions are given by 𝐶(𝑟, 𝑧, 0) = 𝐶𝐴. In between the two phases at the boundary of the 180 
sphere, 𝑟 = 𝑅, we assume continuity in 𝐶 such that 181 
𝐶𝑖𝑛𝑡 = 𝐶𝑒𝑥𝑡,  𝑟 = 𝑅. (7) 
 where 𝐶𝑖𝑛𝑡 here represents the concentration of oxygen at the interior of the spheroid/media 182 
interface and 𝐶𝑒𝑥𝑡 represents oxygen at the exterior. It is also assumed that the flux is equal 183 
such that mass is conserved, i.e., 184 
𝐷1
𝜕𝐶𝑖𝑛𝑡
𝜕𝑟
= 𝐷2
𝜕𝐶𝑒𝑥𝑡
𝜕𝑟
. 
 
𝑟 = 𝑅. (8) 
 185 
A B 
 
 
Figure 2: Model geometry schematics. Hepatic spheroids are formed in vitro via media 186 
incubation whereby the hepatocytes initially seeded aggregate to form uniform spheroids. (A): 187 
Representative Model I schematic of an idealised radially symmetric spheroid. (B): 188 
Representative Model II schematic of a typical Ultra-Low Attachment (ULA) plate well with 189 
media. The oxygen concentration experienced by the cells is dependent on external 190 
concentration in the air and depth of the media. Spheroid position and environmental geometry 191 
are indicated corresponding to measurements provided in Table 1.  192 
 193 
𝑟 = 0 
𝑟 = 𝑅 
h-l 
h 
l a 
r
1
 
r
2
 
p-l p 
V
2
 
V
1
 
 10 
Symbol Description Value 
V1 Well volume 360 l 
V2 Media volume 100 l 
r1 Well radius (top) 3.429 mm 
h Depth of well 11.303 mm 
a Well radius (bottom) 3.175 mm 
l Height of spherical cap  1.6 mm 
r2 Media radius (top) 3.2338 mm 
p Media depth 3.848 mm 
 194 
Table 1: Physical measurements of the geometry of a typical Ultra-Low Attachment (ULA) 195 
plate (Costar 96-well Ultra Low Attachement (Corning Life Sciences, 2018)) with media, 196 
used to culture hepatic spheroids in vitro (see corresponding schematic in Figure 2B). 197 
 198 
2.2 Model parameterisation  199 
Oxygen consumption parameters (𝑉𝑚𝑎𝑥 and 𝐾𝑚) for human hepatocellular cell lines were 200 
obtained using Seahorse Technology, which monitors oxygen consumption rates (OCR) and 201 
extracellular acidification rates (ECAR) in live cells to determine bioenergetic behaviour. The 202 
Seahorse experiments carried out by Kamalian et al. (2018) yielded a panel of OCR values for 203 
both HepaRG and HepG2 cell types. The maximum oxygen consumption rates (corresponding 204 
to 𝑉𝑚𝑎𝑥 in the in silico modelling) were derived by summing the mean non-mitochondrial and 205 
maximal respiration OCR values. These rates were presented per 10,000 cells and thus an 206 
average hepatocyte volume of 3.4×10-15 m3 (Lodish et al., 2000) was used to convert OCR to 207 
the desired units for 𝑉𝑚𝑎𝑥 (mol/m
3/s). Maximum consumption rates were therefore calculated 208 
as 𝑉𝑚𝑎𝑥 = 4.40×10
-2 mol/m3/s for HepaRG cells and 𝑉𝑚𝑎𝑥 = 1.54×10
-2 mol/m3/s for HepG2 209 
cells. It is possible that OCR measured in different cell culture conditions (2D, 3D, suspension, 210 
etc.) may cause the exact value to vary. However, it should be noted that the values used in the 211 
model appear feasible for the system and are the same order of magnitude as 𝑉𝑚𝑎𝑥 values found 212 
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in other multicellular spheroid studies (Leedale et al., 2014, Lesher-Pérez et al., 2017). The 213 
Michaelis constant appears to be more difficult to ascertain as only measurements based upon 214 
rat studies have been made. For this study we use the value for primary rat hepatocytes, 𝐾𝑚 = 215 
6.24×10-3 mol/m3 (Shipley et al., 2011), itself comparable to values used in other studies and 216 
models, based upon rat hepatocytes cultured using a variety of methods (Buerk & Saidel, 1978, 217 
Yarmush et al., 1992, Foy et al., 1994, Colton, 1995, Allen & Bhatia, 2003, Mattei et al., 2017).  218 
To determine oxygen transport parameters, the rate of oxygen diffusion through the spheroid 219 
was derived based on the modelling results of Leedale et al. (2014). This previous model 220 
assumed linear oxygen consumption kinetics and optimised parameter values by fitting to 221 
oxygen distributions in cellular spheroids, measured under various external oxygen conditions. 222 
We repeated the optimisation procedure, using the same data, but for the radially symmetric 223 
diffusion model with saturating uptake (identical to equations (2)), acquiring a better fit and 224 
updated diffusion coefficients. The diffusion rate of oxygen inside the sphere, 𝐷1, was 225 
estimated to be 1.60×10-9 m2/s and the rate outside the sphere, 𝐷2, is 4.85×10
-9 m2/s.  226 
In Model I we prescribe our fixed boundary concentration to be equivalent to the concentration 227 
of oxygen at the periportal region of the sinusoid, 𝐶𝑅 = 65 mmHg (~8.6% O2). In Model II we 228 
prescribe the external far-field concentration to be equivalent to atmospheric oxygen 229 
concentration, i.e., 𝐶𝐴 = 160 mmHg (~ 21% O2). 230 
2.3 Numerical simulation 231 
Model II PDE solutions were obtained using COMSOL Multiphysics software. All other 232 
simulations and plotted model outputs were obtained using MATLAB.  233 
2.4 Cell culture and generation and immunohistochemical staining for hypoxia  234 
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The asymmetry of oxygen distribution during spheroid culture in vitro was motivated and 235 
supported by an illustrative example of immunohistochemical staining and so we provide the 236 
experimental details here for completeness. The human hypopharyngeal carcinoma cell line, 237 
FaDu (American Type Culture Collection) (Rangan, 1972) were cultured in RPMI-1640 238 
medium supplemented with 10% (v/v) fetal calf serum (BioSera), 2 mM L-Glutamine, 100 239 
IU/ml penicillin and 100 µg/ml streptomycin (Sigma) at 37°C in 5% CO2. Tumour spheroids 240 
were generated from FaDu cells using the liquid over-lay method as previously described 241 
(Colley et al., 2014). Briefly, 100 µl of 1.2 x 105/ml FaDu cells were added to each well of a 242 
96-well plate coated with 1.5% type V agarose (w/v in DMEM) and incubated at 37°C, 5% 243 
CO2. Medium was changed every 48 h by removing and re-placing 50% of the medium. Images 244 
of MCTS were captured using a Zeiss Axiovert 200M inverted microscope fitted with a Nikon 245 
AxioCam digital camera and spheroid diameter measured using Axiovision 4.6 software. For 246 
visualisation of hypoxic regions, spheroids were incubated with 170 µM Hypoxyprobe 247 
(Hypoxyprobe, MA) for 2 hours, washed with PBS, fixed in 4% paraformaldehyde, embedded 248 
in agarose (1.5% w/v in 10% PBS-buffered formalin), histologically processed and embedded 249 
in paraffin wax. Sections (5 μM) of wax-embedded spheroids were dewaxed, rehydrated and 250 
endogenous peroxidase neutralised with 3% hydrogen peroxide in methanol for 20 minutes. 251 
Following antigen retrieval with 1% pronase, tissue sections were blocked for 20 minutes at 252 
room temperature with 3% bovine serum albumin and incubated with mouse anti-hypoxyprobe 253 
monoclonal antibody for 1 h at room temperature. Secondary antibody and avidin-biotin 254 
complex provided with Vectastain Elite ABC kit (Vector Laboratories) were used in 255 
accordance with the manufacturer’s instructions. Finally, NovaRed (Vector Laboratories) was 256 
used to visualise hypoxia. Sections were counterstained with 4',6-Diamidine-2'-phenylindole 257 
dihydrochloride (DAPI; Sigma) and mounted with Prolong™ Gold Antifade (Life 258 
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Technologies). Fluorescent images were captured using a spinning disc confocal microscope 259 
(Olympus IX81).  260 
 261 
3 Results 262 
3.1 Model I: Recapitulation of the in vivo sinusoid gradient by fixing the oxygen 263 
concentration at the sphere boundary 264 
The steady state solution for Model I with a HepaRG spheroid radius of 150 m and fixed 265 
periportal (boundary) supply of 65 mmHg is plotted in Figure 3 such that the simulated 266 
distribution of oxygen concentration across the radial distance of the spheroid at equilibrium 267 
can be visualised. Physiologically relevant oxygen concentrations of oxygen within a sinusoid 268 
microenvironment are indicated including desired in vivo oxygen values at the sinusoid 269 
extrema and a value corresponding to hypoxia, defined as 10 mmHg (Martinez et al., 2008). 270 
Under these conditions, the in vivo sinusoid gradient is not replicated with the in silico model 271 
since there is too little oxygen present in the central region of the spheroid. This would suggest 272 
that the size of the spheroid is suboptimal in this scenario and therefore the spheroid radius (𝑅) 273 
was optimised in order to ensure the relevant oxygen concentration at the spheroid core, i.e., 274 
𝐶(0) = 35 mmHg. 275 
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 276 
Figure 3: Simulation of Model I showing the spatial distribution of oxygen concentration 277 
at steady state in an in silico hepatocyte spheroid of radius 150 m with radial symmetry. 278 
Physiologically significant concentrations of oxygen concentration are indicated with 279 
horizontal lines representing the periportal region (black, solid), perivenous region (black, 280 
dashed) and threshold for hypoxia (red, dashed). 281 
 282 
Figure 4 shows how varying the radius of both HepaRG and HepG2 spheroids can be 283 
effectively implemented within the model in order to ensure that the desired oxygen gradient 284 
across the spheroid (in silico sinusoid) is obtained and similarly, in order to predict at what 285 
radius the spheroids are likely to experience hypoxia in the spheroid core (in silico central 286 
vein). HepaRG spheroids have in vivo-like oxygen values at the centre when they are 287 
approximately 100 m in radius. The corresponding optimal radius for HepG2 spheroids is 288 
approximately 170 m. Hypoxia is predicted in the spheroid interior when the radii is greater 289 
than 142 m in HepaRG spheroids and 241 m in HepG2 spheroids.  290 
 15 
A B 
  
 
 
C 
 
 
Figure 4: Mathematical model predictions of optimal sinusoidal oxygen gradients and 291 
hypoxia for hepatocyte spheroids. Oxygen concentration at the spheroid centre (i.e., “central 292 
vein”) is plotted for a range of spheroid radii (black, bold) for both HepaRG (A) and HepG2 293 
(B) cells. Physiologically relevant oxygen concentrations are denoted with horizontal lines for 294 
in vivo central vein oxygen concentration (black, dashed) and hypoxia (red, dashed). Grey bars 295 
represent the percentage of hepatocytes in the spheroid that are hypoxic as radii are increased. 296 
(C): Oxygen concentration profiles for optimal spheroid radii and hypoxic spheroid radii are 297 
plotted against the radial distance from the spheroid centre for both HepaRG (black) and 298 
HepG2 (blue), with physiologically relevant concentrations denoted. 299 
 300 
Whereas HepaRG simulations appear realistic in terms of the often cited ~150 m oxygen 301 
diffusion distance, the estimated size at which HepG2 spheroids begin to suffer central hypoxia 302 
appears to be quite large (Carmeliet & Jain, 2000, Glicklis et al., 2004, Anada et al., 2012). 303 
However, it should be noted that there is evidence that different cell types have different 304 
metabolic demands (Olive et al., 1992) and therefore, all else being equal, it is expected that 305 
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optimal spheroid size should in fact vary with a variation in oxygen consumption kinetics, as 306 
governed by the physical processes described in our mechanistic model. We are not aware of 307 
any exact measurements of local pO2 in HepG2 spheroids but it has been shown that HepG2 308 
cells consume oxygen at a much lower rate than primary hepatocytes (Nyberg et al., 1994). 309 
Furthermore, our definition of hypoxia (𝐶 < 10 mmHg) may be overly prescriptive compared 310 
to other studies, e.g. 40 mmHg (Curcio et al., 2007), and we do not account for other 311 
environmental factors (i.e., pH, glucose, etc.) or cell death as indicators for limitations in 312 
spheroid size - only the physical processes of oxygen diffusion and consumption. In light of 313 
these considerations we opt to carry out the rest of our investigation based on the HepaRG cell 314 
line to focus on the impact of well geometry on oxygen dynamics in the in vitro spheroid 315 
system, but stress that attention should be paid to different cell line metabolic demands when 316 
considering optimal size for recapitulation of hepatic O2. Moreover, the HepaRG cell line is 317 
potentially more relevant for optimisation since these spheroids do not proliferate once 318 
differentiated and more closely resemble in vivo functionality (Gunness et al., 2013).  319 
3.2 Model II: Recapitulation of the in vivo sinusoid gradient within a representative in 320 
vitro environment 321 
Model II adopts radial symmetry in cylindrical coordinates, with the central vertical axis of the 322 
well (top-to-bottom) representing the central axis of symmetry, and takes into account the 323 
diffusion of oxygen through the media as well as inside the hepatocytes as before. The output 324 
of Model II differs to Model I in two key ways. Firstly, the oxygen concentration at the 325 
boundary of the spheroid is no longer explicitly specified and imposed as a constant value, but 326 
rather depends on the concentration at the media-air interface (atmosphere) and subsequent 327 
dynamic effects of diffusion through the media, flux into the spheroid and consumption within 328 
the spheroid. Secondly, the spatial oxygen dynamics within the spheroid are no longer 329 
symmetrical about the centre of the spheroid due to the position of the spheroid within the well 330 
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and the location of the oxygen source, at the top of the well (Figure 5). This asymmetric 331 
distribution of oxygen concentration is supported experimentally by observed distributions of 332 
hypoxia within spheroids in culture (e.g., see hypoxic FaDu spheroid in Figure 6C). By 333 
quantifying regions of hypoxia using relative light units, it is clear that more hypoxic conditions 334 
are observed towards the bottom of the in vitro spheroid (Figure 6D-E). The asymmetry within 335 
the hepatic spheroid of the in silico model can be visualised more clearly by a 1D representation 336 
of the spatial oxygen dynamics through a central axis of symmetry cross-section (Figure 6A-337 
B). It is clear from this representation that the minimum oxygen concentration is not found at 338 
the centre of the spheroid but at a distance closer to the bottom of the well. For example, under 339 
the modelling conditions of a HepaRG spheroid of radius 150 m in 100 l of media, the 340 
minimum oxygen concentration is predicted to be approximately 16 mmHg at 129 m from 341 
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the bottom of the well (i.e., ~20 m away from the core, at the distal side of the spheroid, 342 
relative to the oxygen source).  343 
 344 
 345 
Figure 5: Simulated 3D spatial oxygen dynamics within the in vitro culture environment. 346 
Model II simulation results for a geometrically relevant environment to represent the spatial 347 
distribution of oxygen concentration for hepatic spheroids cultured in vitro. The model output 348 
represents the steady state solution for a HepaRG spheroid of radius 150 m in 100 l of media. 349 
The results can be visualised in 2D due to the axisymmetric nature of the problem and the 350 
region containing the hepatic spheroid is highlighted for clarity. 351 
 352 
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Figure 6: 1D cross-section of spatial oxygen dynamics. (A): 1D cross-section of the model 354 
simulation described in Figure 5 with respect to the axisymmetric z-axis (represented as 355 
distance from the bottom of the well). (B): The same results are plotted for a reduced spatial 356 
range to visualise oxygen dynamics within the spheroid more clearly. Solid and dashed 357 
horizontal black lines indicate desired oxygen concentrations for periportal and perivenous 358 
zones within the liver. Horizontal red dashed lines represent the threshold for hypoxia. Vertical 359 
green dashed lines represent the centre of the spheroid. Vertical black dashed lines represent 360 
the spheroid boundary. (C): Example of an in vitro spheroid exhibiting asymmetrical oxygen 361 
distribution. Image represents immunohistochemical staining of a hypoxic FaDu spheroid with 362 
cell nuclei indicated in blue and hypoxia in red. The red arrow indicates a representative z-axis. 363 
(D): Spatial plot of the relative light intensity (RLI) of hypoxia within the spheroid. Blue lines 364 
indicate the representative z-axis relative to the bottom of the well (solid) and a cross-section 365 
through the centre of the spheroid (dashed, for comparison with (E)). (E): Hypoxia RLI versus 366 
distance from the top of the spheroid. RLI (red) is calculated for each position along the z- axis 367 
from the top to the bottom of the spheroid. The spheroid centre is also indicated (blue dashed 368 
line). 369 
 370 
Ideally, in order to optimise the in vitro system to be more representative of the hepatic oxygen 371 
range observed in vivo, the maximum oxygen concentration within the spheroid would 372 
z 
100 µm 
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correspond to that in the periportal blood and the minimum oxygen concentration would 373 
correspond to that in the perivenous blood. One experimentally convenient method to vary the 374 
local oxygen concentration experienced by the spheroid is to adjust the media volume. Thus, 375 
the identification of optimal conditions for replicating the desired oxygen gradient can be 376 
investigated by comparing variations in both media volume and spheroid radius. By calculating 377 
the steady state solutions of Model II for a relevant range of media volumes (50-300 l) and 378 
spheroid radii (100-250 m), the oxygen concentrations at specific locations within the 379 
geometry can be compared for optimisation (Figure 7). The two primary quantities of interest 380 
are the maximum oxygen value at the spheroid boundary (Figure 7A) and the minimum 381 
concentration within the spheroid (Figure 7C). We also calculate an average oxygen value 382 
(Figure 7B) in acknowledgement of the heterogeneity across the boundary (e.g., see Figure 5). 383 
Spheroid-radius/media-volume parameter combinations are optimised by identifying the 384 
values that provide the desired oxygen concentration in each region, indicated by solid white 385 
contours in Figure 7. A dashed white contour in Figure 7B also denotes at which radii/volume 386 
hypoxia is predicted to occur within the spheroid. The variation in oxygen concentrations 387 
appears to be more significant with spheroid radius rather than media volume, and so this 388 
parameter is deemed more sensitive within these relevant physical ranges. 389 
 21 
A 
 
 
B 
C 
Figure 7: Identification of in vivo oxygen concentrations for different in vitro culture 390 
conditions in two distinct spheroid regions. Steady state oxygen concentrations are 391 
calculated for a range of spheroid radii and media volumes representing the maximum (A) and 392 
average (B) spheroid boundary values, and the minimum values within the spheroid (C). Solid 393 
white contours represent the curve along which the oxygen concentration is equal to the desired 394 
in vivo value for periportal (A, B) and perivenous (C) regions. The dashed white contour 395 
indicates which spheroid radius and media volume combinations lead to hypoxia within the 396 
spheroid as predicted by the mathematical model. 397 
 398 
For a given spheroid radius, the mathematical model can suggest what amount of media volume 399 
leads to physiologically relevant oxygen concentrations at the boundary and at the minimum. 400 
However, it should be noted that the two optimal contours provided in Figure 7 do not intersect 401 
within the relevant ranges of radius and volume parameters. This is more clearly indicated in 402 
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Figure 8, where the contours are collated onto the same plot. Therefore, in order to optimise 403 
the in vitro system within these physical ranges, it is not possible to simultaneously satisfy both 404 
conditions for the desired in vivo gradient, and thus an intermediate region in parameter space 405 
must be identified which optimally satisfies the problem with minimum error. The percentage 406 
error associated with each combination of spheroid radius and media volume is calculated by 407 
combining the absolute differences at both the maximal spheroid boundary and minimum 408 
oxygen value within the spheroid according to the following formula: 409 
Combined % error =
1
2
(
|𝐶𝑚𝑎𝑥 − 𝐶𝑃𝑉|
𝐶𝑃𝑉
+
|𝐶𝑚𝑖𝑛 − 𝐶𝐶𝑉|
𝐶𝐶𝑉
) × 100 (9) 
This error is plotted across the parameter space in Figure 8A and the minimum error can 410 
subsequently be identified, corresponding to a spheroid of radius 131.82 m and media volume 411 
of 300 l. The 1D oxygen profile for this parameterisation can be seen in Figure 8B. Note that 412 
even a significant increase in media volume yields little improvement in the minimisation of 413 
the combined % error (e.g., a media volume of 600 l, with spheroid radius of 127.27 m, 414 
decreases the error from 27.2% to 23.6%, and the contours do not intersect for media volumes 415 
up to 5×104 l – data not shown). In Figure 8B, the compromised oxygen gradient can be 416 
clearly visualised whereby the minimal oxygen concentration is optimal and well above the 417 
hypoxic threshold, but the maximal, and even the average oxygen concentration around the 418 
spheroid boundary (indicated in red), are above the desired periportal value. Nevertheless, these 419 
optimal values provide a range of oxygen values which encompass the desired sinusoid 420 
gradient. However, analysis of the sensitivity of the model discrepancy to perturbations in these 421 
optimal parameters reveals that the HepaRG spheroid is a sensitive system, with a 20% 422 
decrease in the spheroid radius (~105 m) leading to a +69% average error in the optimal 423 
oxygen values and a 20% increase in the spheroid radius (~158 m) resulting in a -57% average 424 
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error (Figure 9).  Furthermore, it should be noted that, in this scenario, the model predicts that 425 
an increase in radius of just 17.18 m (or measurement error of 17.18 m) will lead to the onset 426 
of hypoxia within the spheroid. 427 
A B 
 
 
 428 
Figure 8: Error calculation and minimisation in order to identify overall optimal in vitro 429 
culture conditions. (A): Figure 7 contours for the optimal conditions that provide desired 430 
maximum spheroid oxygen concentration (solid, black), minimum spheroid oxygen 431 
concentration (solid, blue) and hypoxia (dashed, red) are collated onto a single plot. This plot 432 
shows the overall optimal operating conditions for the relevant ranges of spheroid radii and 433 
media volume through the calculation of a combined % error. The minimum error is indicated 434 
by a red circle. Note that in order to prevent hypoxia, the operating conditions should lie to the 435 
left of the hypoxic threshold. (B): The 1D oxygen profile corresponding to the minimum error 436 
parametrisation (red circle, (A)), is plotted with the same format and annotations as in Figure 437 
6. The red dot indicates the average spheroid boundary concentration around the entire 438 
spheroid. 439 
 440 
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 441 
Figure 9: Error sensitivity analysis of the optimal operating conditions proposed by Model 442 
II for HepG2 spheroids. The percentage error for both the minimum oxygen concentration 443 
(red) and the maximum boundary concentration (blue) in the spheroid are plotted for variations 444 
in the optimal spheroid radius (131.82 m) in 300 l of media. An average error is also 445 
indicated (white line). The optimal spheroid radius to recapitulate the oxygen gradient (black 446 
line) and radius threshold for hypoxia (red line) are also shown.   447 
 448 
4 Discussion 449 
Optimisation of the in vitro hepatic spheroid system requires that culture conditions are 450 
calibrated such that physiologically relevant oxygen ranges are established. Mathematical 451 
models provide a means of testing the system in order to optimise physical system parameters 452 
in order to obtain desired system properties and consequently guide the process of 3D in vitro 453 
study design. Specifically, a model that is properly parameterised for intrinsic physiological 454 
processes (e.g. oxygen consumption rate, diffusion rate of oxygen) can be used to identify and 455 
optimise parameters such as media volume or spheroid radius that lead to the establishment of 456 
the in vivo-like hepatic sinusoid oxygen gradient. Consequently, such in silico models directly 457 
inform the design of experiments aiming to reproduce liver physiology in vitro. 458 
Several insightful results regarding the optimal culture conditions have been acquired through 459 
the development and analysis of two mechanistic mathematical models, parameterised using 460 
experimental data. Provided one could ensure the fixed physiological oxygen concentration at 461 
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the spheroid boundary, Model I predicts that sinusoid gradients can be achieved for HepaRG 462 
and HepG2 spheroids of radii 100 m and 170 m respectively (with the onset of hypoxia 463 
occurring at 142 m and 241 m). HepG2 spheroids can afford to grow to a larger size without 464 
experiencing hypoxia due to the reduced demand for oxygen (lower oxygen consumption rate, 465 
𝑉𝑚𝑎𝑥). This lower demand in oxygen may be due to the finding that in their unstressed state, 466 
HepG2 cells produce cellular energy from both oxidative phosphorylation and anaerobic 467 
glycolysis, due to the Warburg effect, and thus a reduced oxygen consumption rate is measured 468 
due to the additional production of ATP via glycolysis (Kamalian et al., 2018). Conversely, 469 
HepaRG cells only produce ATP via oxidative phosphorylation in the unstressed state and so 470 
would need to consume more oxygen to produce the same amount of ATP. However, Model I 471 
assumes the spheroid is cultured in a 3D radially symmetric environment whereas this 472 
assumption is not valid in most experimental models. The extension of Model II to a more 473 
realistic well geometry means that the precise end-points of the in vivo sinusoid gradient cannot 474 
simultaneously be satisfied for any given combination of spheroid radius and media depth 475 
combination. Therefore, culture conditions are identified by the model that minimise the 476 
potential error of the end-points at the average spheroid boundary and minimum oxygen value 477 
within the spheroid. This optimisation corresponds to a HepaRG spheroid radius of 132 m 478 
(with a revised hypoxic threshold of 149 m) and 300 l of media volume, which is in contrast 479 
with more common instructions for culturing spheroids in 100 l media (Korff, 2004, Charoen 480 
et al., 2014, Morrison et al., 2016). However, the model oxygen gradient is more sensitive to 481 
the spheroid radius parameter, and thus careful consideration should be given for spheroids that 482 
change size over the defined culture period. In particular, sensitivity analysis reveals that small 483 
perturbations in spheroid radius can lead to larger average errors in the gradient, relative to the 484 
perturbation, and therefore precision is required to avoid the onset of hypoxia while preserving 485 
central vein values. The application of both Models I and II suggest that there is a difference 486 
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in predicted optimal spheroid size when you take into account well geometry and oxygen 487 
diffusion through the media.  488 
Another cell culture system currently used within the field comprises a multi-well plate with a 489 
gas-permeable bottom, covered with agarose to form U-shaped layer. This system is designed 490 
to improve the delivery of oxygen to multicellular spheroids and prevent necrosis in the centre 491 
of the spheroid. This feature, in combination with a U-shaped agarose layer, could alleviate the 492 
asymmetry of the oxygen profile in ULA plates. This alternative system was therefore 493 
implemented within our mathematical modelling framework by replicating the geometry for 494 
Model II with the further addition of 100 µl of agarose to form a U-shaped layer with a flat, 495 
gas-permeable bottom at the bottom of the well (for details of the investigation, see 496 
Supplementary Material). The results of this study (complementary to that of the ULA plate) 497 
showed that indeed, while symmetry was improved and larger non-hypoxic spheroids could be 498 
cultured, it was still not possible to achieve the desired in vivo gradient exactly. Model analysis 499 
identified a desired central oxygen concentration of 35 mmHg for an optimised 145.45 m 500 
radius spheroid in 300 l media. However, oxygen at the spheroid boundary, whilst relatively 501 
homogenous compared with the ULA plate system, remained too high for atmospheric external 502 
oxygen tensions.  503 
The calibration and optimisation of intra-spheroidal oxygen profiles may also be improved via 504 
the controlled regulation of oxygen tensions within a cell culture incubator. The presented work 505 
has focused on the atmospheric oxygen levels commonly utilised within cell culture 506 
experiments. However, these non-physiological levels could result in hyperoxia if the media 507 
volume or spheroid size is insufficient (Gomes et al., 2016). Indeed, this issue can be seen for 508 
such scenarios as simulated by our model (e.g., Figure 7). Additionally, the use of further 509 
alternative cell culture formats may improve recapitulation of the in vivo sinusoid gradient in 510 
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hepatic spheroids. It is possible that the geometry of the hanging drop system would provide a 511 
more uniform, symmetric oxygen profile; however, this system uses a very small volume of 512 
liquid and so issues regarding waste products, medium changes and tight control of the oxygen 513 
environment must be considered. The culture of multiple small aggregates in a single well has 514 
also been shown to influence the oxygen distribution and lower steady state values and could 515 
therefore potentially be used as an optimisation tool (Lesher-Pérez et al., 2017). 516 
Mathematical models comprise a useful tool for simulating physical problems, testing 517 
hypotheses in silico, and guiding subsequent experimental work. However, they are inherently 518 
simplified and abstract for tractability, and while driven by experimental data for calibration, 519 
it is also important to acquire feedback in the form of empirical data and continue model 520 
refinement. Thus, successful (i.e., useful) models (both mathematical and experimental) are the 521 
result of the iterative cycle between in silico and in vitro work.  This model was implemented 522 
to thoroughly and efficiently analyse the physical and mechanistic conditions that influence 523 
spatial oxygen distribution in hepatic spheroids in view of commonly practised cell culture 524 
methodologies. The model simulates outputs that are inefficient and difficult to 525 
comprehensively obtain in vitro, but would now benefit from testing and verification 526 
experiments including local, real-time measurements of oxygen and evidence of hypoxic levels 527 
within the spheroid under specified scenarios.  528 
Many previous in silico models have focused on oxygen kinetics in spheroids, highlighting the 529 
importance of properly characterising these mechanisms that describe the underlying 530 
biophysical processes. Most of these models rely on symmetrical properties or biochemical 531 
parameters derived from tumour spheroids. Such modelling work covers a range of applications 532 
that ultimately emphasise the need for optimisation of these in vitro systems, whether through 533 
the optimisation of spheroid morphology (Leung et al., 2015), defining optimal spheroid 534 
viability and functionality (Glicklis et al., 2004), or accounting for perfusion velocity and flow 535 
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within microbioreactors (Allen & Bhatia, 2003, Hu & Li, 2007, Barisam et al., 2018). Some 536 
key novelties arising from our multidisciplinary modelling work include the measurement of 537 
oxygen uptake parameters that are integrated into mathematical models to generate bespoke 538 
dynamics for both HepG2 and HepaRG cell lines; the development and parameterisation of a 539 
model that takes into account a realistic ULA geometry with, most importantly, asymmetry; 540 
and an improved guide for media volume conditions in these environments relevant to hepatic 541 
spheroid culture. The utility of this spheroid mathematical modelling framework can be further 542 
extended to incorporate drug transport and metabolism components in a similar approach, 543 
ultimately providing a more realistic description of the environment and culturing conditions 544 
used in vitro for improved medical applications. 545 
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